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INTRODUCTION 
Research has shown that tight control of blood glucose can decrease or eliminate 
some long-term complications from Diabetes Mellitus (DM) (I, 2). Maintaining blood 
glucose levels under tight control has been addressed in the inpatient as well as in the 
outpatient setting (I, 2). If maintaining appropriate blood glucose levels on an outpatient 
basis diminishes complications, does tight control during the perioperative period prevent 
infectious complications as well? 
It is this question, exclusively in the case of diabetic patients who are going 
through surgery, which will be the focus ofthis paper. Here, I will examine the evidence 
for glucose control as it relates to postoperative infections. I will see if sufficient 
evidence to make clinical recommendations is available. Groups 1have published their 
recommendations and guidelines on perioperative glycemic control in diabetic patients 
(3, 4, and 5). Therefore, in the final section of this paper, I will critique 
recommendations made by various groups against this evidence base and make 
suggestions for future research in this area. 
BACKGROUND ON DIABETES MELLITUS 
Diabetes Mellitus (DM) is the most common endocrine disorder. It is subdivided 
into several different classifications that are based on insulin deficiency and insulin 
resistance. The two major classifications are Type I and Type 2. Type 1 DM is defined 
as beta cell destruction with a resultant lack of insulin production capacity. Type 2 DM 
is defined as insulin resistance with insulin deficiency. 
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The pathophysrology of Type 1 DM is well known; however, the pathophysiology 
of Type 2 DM is less clear. It is common knowledge that in Type 2 DM, organs that use 
insulin (primarily muscle and liver) are not able to take up glucose due to insulin 
resistance. This results in decreased uptake and storage of glucose in muscle and 
inappropriate hepatic glucose production (6). To compensate for high blood glucose 
levels, the body attempts to rectify the situation by increasing circulating insulin. 
However, in the presence of insulin resistance, glucose levels remain elevated. Increased 
circulating insulin causes an increased lipogenesis and an increase in fat stores thus 
helping to perpetuate a vicious cycle. 
Some inciting factors for the development of Type 2 DM may include high 
circulating free fatty acids, cortisol and catecholamines ( 6). Additionally, there is a 
genetic aspect to this disease with a strong environmental influence on expression. Twin 
studies demonstrate a greater than 30 percent concordance among monozygotic twin 
pairs in the expression of Type 2 DM (6). Moreover, a sedentary lifestyle, high-fat diet 
and belonging to certain ethnic groups (e.g. African Americans, Native Americans and 
Hispanics) are also contributing factors to the development ofDM. 
Diabetes is a highly prevalent disease. The number of affected patients increases 
every year. The CDC reports approximately 4.2 percent of the adult U.S. population as 
having some form of diabetes. This represents approximately 15 million Americans, 
90% of which suffer from Type 2 DM (7). Additionally, there are approximately 16-20 
million with impaired glucose tolerance (IGT) or impaired fasting glucose (IFG), both of 
which are considered "prediabetes" (8). 
1 The American Diabetes Association (ADA); the American Healthways Inc; Dr. Alex Stagnaro-Green 
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Type 1 DM is usually seen in young children or adults but can occur at any age. 
Type 2 DM can occur at any age, but incidence increases with age. The American 
Diabetes Association (ADA) reports that 8 up to 45 percent of children with newly 
diagnosed diabetes have Type 2 DM (9). This represents an increase from an estimated 8 
percent in 1994 (9). This increase in prevalence is not limited to children and 
adolescents. The prevalence of diagnosed diabetes in U.S. adults increased from 4.9 
percent in 1990 to 6.5 percent in 1998 (10). 
Complications Associated with Diabetes L 
The American Diabetes Association (ADA) suggests that tight control of blood 
glucose is defined as a preprandial (fasting/premeal) plasma glucose of90-130 mg/dL, a 
postprandial (postmeal) plasma glucose of II 0 -170 mg/dL, and a bedtime glucose of i 
100- 160 mg/dL (3). The Diabetes Control and Complications Trial (DCCT) and The F 
United Kingdom Prospective Diabetes Study (UKPDS) demonstrated that patients whose 
blood glucose levels were kept within the recommended ranges on an outpatient basis 
had fewer complications from diabetes (I, 11 ). Blood glucose levels not kept in these 
recommended ranges resulted in patients developing more diabetic complications (1, 11 ). 
Diabetic complications can be microvascular (e.g., nephropathy, neuropathy, and 
retinopathy) and/or macro vascular (e.g., cardiovascular or cerebrovascular disease). All 
of these complications can decrease both the quality and quantity oflife for patients. 
However, studies indicate that one way to reduce a patient's risk of developing these 
complications is to intensively treat his or her diabetes (I, 11 ). 
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The Diabetes Control and Complications Trial (DCCT) demonstrated that 
intensive control of blood glucose reduced the risk of microvascular progression of 
retinopathy and nephropathy (1 ). The United Kingdom Prospective Diabetes Study 
(UKPDS) demonstrated that in Type 2 DM, tight glucose control prevented or delayed 
nephropathy, neuropathy and retinopathy (11). Additionally, the more normal a patient's 
HbA1c (a measure of the average glucose in a patient's blood over two or three months), 
the lower the patient's lipid levels. This combination decreased the patient's risk of 
developing Coronary Heart Disease (CHD) (11 i. 
Secondary to the many complications encountered by Type 2 DM patients, they in 
comparison to non-diabetics, have an increased likelihood of needing extensive and 
repeated inpatient medical care (12). The National Health and Nutrition Examination 
Survey (NHANES II), conducted from 1976 until1980, showed that 29.9 percent of 
persons 65 and older with known diabetes, in comparison to non-diabetics, have been 
hospitalized for diabetes-related conditions and other medical reasons (12). The 
investigators estimated that hospitalizations were 1. 7 times more common for elderly 
patients with diabetes than those without diabetes (12). 
Cost Associated with Diabetes 
Healthcare expenditures for people with diabetes are approximately 17 percent of 
all U.S. health care expenditures totaling approximately $105 billion dollars annually (7). 
Over 4 million people with diabetes are admitted to a hospital each year, and the number 
of admissions is increasing by 4.5 to 5.0 percent annually (4). 
2 CHD ~ fatal or non fatal MI, or angina with abnormal ECG. 
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Diabetic patients comprise 20 percent of all hospital admissions. Twenty-five 
percent of all hospital stays and nearly 25 percent of all hospital charges are attributed to 
diabetic patients ( 4). The current annual total hospital cost for people with diabetes 
exceeds $98 billion (II). Total inpatient resource consumption and length of stay for a 
diabetic patient are 30 to 40 percent more than that of hospitalized non-diabetic patient 
( 4). Consequently, the morbidity and costs associated with diabetes have resulted in 
inpatient management strategies focused on improving outcomes and implementing cost-
effective methodologies. L 
OBJECTIVES 
It is known that tight glucose control on an outpatient basis over time has been 
I shown to decrease long-term diabetic complications (1, 11). The paper will review 
published literature on perioperative infections relating to glucose control in diabetic 
surgical patients. The objective of this systematic review is to determine what, if any, 
effect glucose control has on the type, length and severity of infectious outcomes. 
PRIMARY QUESTION: 
Does better glycemic control reduce perioperative infections? 
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METHODS 
Identification and Retrieval of Primary Studies 
Search Strategy: Searches were conducted for studies that examined perioperative 
outcomes in diabetic surgical patients comprised by papers indexed by Medline from 
1966 to 2003, the Cochrane Clinical Trials Registry (1st quarter 2003), and an evidence-
based medicine database that included the Cochrane Database of Systematic Review 
(CDSR) (1st quarter 2003), the American College of Physicians (ACP) Journal Club (1st 
quarter 2003), and the Database of Abstracts of Reviews of Effectiveness (DARE) (1st 
quarter 2003). Reference lists of relevant review articles and included articles were 
screened for other, previously unidentified, studies. The search strategies were as I follows: 
Medline 1966 to 2003 
# Search History Results 
I (diabetes and (surgery or surgical or operative)).mp. [mp=title, 5925 
abstract, case registry/ec number word, mesh subject heading] 
2 Limit l to (human and English language) 2203 
3 (glucose and control). mp. [mp=title, abstract, cas registry/ec number work, 38236 
mesh subject heading] 
4 Limit 3 to (human and english language) 17772 
5 2 and4 180 
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Cochrane Clinical Trial Registry 
# Search History Results 
1 glucose control.mp. [ mp=iitle, original title, abstract, 288 
mesh headings, heading words, keyword] 
2 diabetic patients.rnp. [ mp=title, original title, abstract, 2068 
mesh headings, heading words, keyword] 
3 surgical patients.mp. [ mp=title, original title, abstract, 1058 
mesh headings, heading words, keyword] 
4 1,3 and 4 103 
CDSR, ACP Journal Club, DARE 
# Search History Results 
1 glucose control.mp. [rnp=title, original title, abstract, 45 
mesh headings, heading words, keyword] 
2 diabetic patients.mp. [ rnp=title, original title, abstract, 54 
mesh headings, heading words, keyword] 
3 surgical patients.mp. [ mp=title, original title, abstract, 107 
mesh headings, heading words, keyword] 
4 1,3 and 4 9 
Inclusion Criteria 
The following criteria were used for the inclusion of studies into the systematic review: 
1. Study goals must have been primarily to find an association between blood 
glucose levels and perioperative infections. 
2. Study must have specified the diabetic status of the patient population at the 
beginning of the study as well as the type of surgical procedure performed. 
3. Study must have selected outcomes directly related to the operation performed 
and not to a previously known diagnosis. 
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4. Study must have reported serum blood glucose levels or HgAlc with respect to 
outcome measures. 
5. Study must have included operations that required at least an overnight hospital 
admission. 
6. Study must have used human subjects and have been published in English. 
Exclusion Criteria 
The following criteria were used to exclude papers from further consideration: 
1. No comparison group or control group, 
2. Retrospective study design, or 
3. No information on inpatient glucose control. 
Full text copies of all potentially relevant studies were obtained by reviewing 
abstracts from both electronic and manual searches. I manually searched the references 
of the electronically obtained abstracts that I included in the study to identify articles 
overlooked by the electronic searches. I planned to do a meta - analysis if the 
interventions, outcomes, and study methodology ofthe selected studies were similar and 
otherwise will perform a narrative assessment. 
I found no randomized controlled trials (RCTs) that addressed tight versus loose 
glycemic control in diabetic surgical patients. Since I did not find this type of article, I 
used the only two observational cohort studies I found during the search. Cohort study 
quality was assessed using the following questions from the Clinical Epidemiology: The 
Essentials (13). 
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1. Are all members of the cohort at risk for developing the outcome? 
2. Is there complete follow-up on all members? 
3. Are all members of the cohort assessed for outcomes with the same intensity? 
4. Are comparisons unbiased? 
Additional quality criteria specific to this type of studies were considered. I included 
the following nine criteria because they addressed the information that the Users' Guides 
to the Medical Literature: A Manual for Evidence-Based Clinical Practice indicated as 
needed in evaluating the quality of a cohort study (14, 15). The criteria are detailed for 
each study in Table 5: 
1. DM definition-- A specific glycemic threshold, use of glucose-lowering agents, 
or both to define diabetes. 
2. DM surveillance --A protocol to detect DM describes the proportion of patients 
not identified in initial screening of patients for study. 
3. Risk factor for postoperative infection ascertainment-- methods to determine risk 
factors were described and applied to study and control subjects alike. 
4. Risk factor for postoperative infection reporting --reports all factors evaluated 
(not just those considered significant). 
5. Outcomes definition --diagnostic criteria for all outcomes assessed were 
described. 
6. Outcomes ascertainment --methods to determine outcomes were described and 
similarly applied to patients with and without outcome of interest. 
7. Outcomes blinding-- outcomes were assessed by investigators blind to diabetic 
status. 
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8. Outcomes reporting- outcomes obtained by the investigators were described. 
9. Outcomes adjustment-- prognostic estimates were adjusted for differences 
between those with and without outcome of interest. 
Quality criteria noted above were listed as present, not present or unable to 
be determined. This method was selected in order to assess the overall quality of each 
study based on factors that were major methodological components of a research 
study on this particular topic. In addition, Bradford-Hill criteria will be used to 
determine ifthere is evidence that an association also had a cause and effect 
relationship. These criteria are as follows (13): 
1. Temporal relationships between cause and effect- Cause precedes effect. I 2. Strength of Association- A strong association is expressed by a large 
measure of effect. 
3. Dose-Response Relationships - Larger exposures to purported cause 
associated with higher rates of disease. 
4. Reversibility- Reduction in exposure associated with lower risk of 
disease. 
5. Consistency - Repeatedly observed by different persons, in different 
places, circumstances, and times 
6. Biologic plausibility- Makes sense, according to biologic knowledge of 
the time. 
II 
Data abstracted from the studies by the reviewer was entered into evidence 
tables. This data included glucose levels in control and intervention groups, statistical 
significance of outcome differences between or among groups, and absolute and 
percentage change in perioperative outcomes in both the control and intervention 
groups. Estimates of effects with p-values or 95% confidence intervals (Cis), as 
appropriate, were recorded. 
RESULTS 
Study Identification L 
A total of 292 citations were identified in the computerized database search. The 
citations identified included 180 from Medline, 103 from CCTR and 9 from the CDSR, 
ACP Journal Club, and DARE databases combined. All292 abstracts were reviewed. 
Studies unrelated to the objectives of this review were eliminated. Forty-one articles 
were subjected to full text review. An additional study, which was identified from 
reference lists, was also fully reviewed. 
Forty-two studies meeting initial screening criteria received a more detailed 
evaluation. Thirty-nine studies were excluded for the following reasons: 8 were 
umelated to glucose control, 9 assessed operative risks but not specific outcomes, 16 
focused on management of diabetes during surgery but did not address glucose control 
with respect to outcomes, 2 addressed insulin protocols with no perioperative outcome 
evaluation, and 4 were retrospective. 
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Two included studies met the inclusion criteria for review. Neither study 
randomized patients into tight versus standard control or blindly assessed outcomes. The 
first study focused on perioperative nosocomial infection rates in diabetic patients 
undergoing elective surgery (16). The second study dealt with infectious complications 
among diabetics who had coronary artery bypass surgery (2). This study addressed three 
types of postoperative infections including wound infection (2). In the studies that were 
included, the control group received usual care, which was not further specified by the L 
authors. 
The two studies included used a prospective cohort design. One study also used 
the members in the cohort to develop a case control study (2). Based on these I differences between the two studies, the heterogeneity of settings, perioperative 
outcomes, varying operation procedures and patient populations, I decided not to conduct r 
a statistical meta-analysis pooling the results of studies. A narrative synthesis of this 
body ofliterature forms the next section of this paper. 
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Results of Studies 
A Study Focusing on Multiple Sites of Infection 
Golden et al examined the relationship between perioperative glycemic control 
and the subsequent risk of infectious complications, such as leg or chest wound 
infections, pneumonia, and urinary tract infections (UTis) (Table 1 ). The researchers 
observed 411 adults with diabetes who underwent coronary artery surgery from 1990 to 
1995 on the cardiac surgery service of an urban university hospital (2). Patients were 
chosen based on chart review, diabetic status verified from doctor's documentation, ER L 
E 
note, admission orders, nursing database or discharge summaries from previous hospital 
admissions (2). 
This study compared two prospective cohorts against each other. The patients 
were followed from 36 hours post operatively and their baseline data was also collected. 
The researchers then gathered a second set of outcome data from postoperative day 2 
until discharge to create a 48-hour lag between exposure and outcome. 
Postoperative glycemic control was characterized by the mean of six capillary 
glucose measurements taken during the 36-hour interval following surgery. The major 
outcomes examined were infections of the leg and chest, pneumonia and urinary tract 
infections. In their analysis, the mean postoperative glucose levels were divided into 
quartiles: quartile 1 (121- 206 mg/dL), quartile 2 (207- 229 mg/dL), quartile 3 (230-
252 mg/dL) and quartile 4 (253- 352 mg/dL) (2), 
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The authors used these quartiles to compare postoperative outcomes for diabetic 
patients. The researchers compared the relative odds of infectious complications among 
patients in the second, third, and fourth quartiles with those in the first quartile. With this 
information, the researchers constructed a series of multiple logistic regression models 
(2). To determine the independent association between glycemic control and the risk of 
infection, the authors adjusted in quartiles for age, sex, race, Charlson Comorbidity 
Index, Acute Physiology and Chronic Health Evaluation (APACHE III) score, and length 
of stay in the surgical intensive care unit (2). 
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The Charlson Comorbidity Index tool for assessing the presence of comorbid 
conditions based on past medical history information found in the admission note and the 
problem list from the patients discharge summary in the index and their possible effects 
on the outcome were used by the researchers. 
To assess the overall severity of illness, Golden eta! used the APACHE III 
prognostic system. The APACHE III score is a predictor of in-hospital mortality in 
critically ill patients (2). The score is a function of the following variables: temperature, 
heart rate, mean blood pressure, respiratory rate, arterial pH, pulmonary carbon dioxide 
concentration (pC02), pulmonary oxygen concentration (p02), sodium, blood urea 
nitrogen, creatinine, glucose, leukocyte count, hemotocrit, total bilirubin, albumin, urine 
output, and neurological status (2). 
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After adjusting for confounders, the relative odds ratios for infection among 
individuals in quartiles 2, 3, and 4 were 1.17 (0.57- 2.40), 1.86 (0.94-3.68), and 1.72 
(0.86-3.47) respectively, in comparison to individuals in quartile 1(2). There was no dose 
response relationship with these odds ratios which argues against a clearly causal 
relationship. Additionally, these differences were not significant since the Cis for these 
relative odds ratios (RORs) all overlap 1.0. 
The researchers wanted to exclude the possibility of a subclinical infection during 
the first 36 hours postoperatively, which could have accounted for findings of an 
increased infection risk. (2). Therefore, Golden et a! performed a secondary analysis 
excluding individuals who developed infectious complications on postoperative day 2 
(2). Nevertheless, a similar result was found after adjusting for all the confounders 
measured at the 36-hour time period. 
The relative odds of infection among individuals in quartiles 2, 3 and 4 were 
somewhat higher with relative odds ratios and CI's as follows: (0.94 (0.39-2.26), 1.59 
(0.71-3.54), and 1.78 (0.79-4.05)). Although there appeared to be a trend of increased 
infection risk with increased glucose levels, the CI's for each of these RORs again 
overlap 1.0 such that these differences were not statistically significant. This lack of an 
association may be secondary to the relatively small sample size for each quartile or a 
true lack of association. 
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A Study Focused on Nosocomial Infections 
Pomposelli eta! examined prospectively the effects of glucose control on diabetic 
surgical patients with respect to nosocomial infection rates (Table 1 ). One hundred 
initially uninfected diabetic patients undergoing elective surgery were monitored for 
perioperative glycemic control and postoperative nosocomial infection rate. Three of 
these patients were excluded when preoperative infections were found. Serum blood 
glucose measurements were collected preoperatively and on postoperative day (POD) 1 
and 2 for the remaining 97 patients (16). Patients were excluded from statistical analysis 
on days when no glucose determinations were available. 
Preoperative patient characteristics and the type of operation performed 
were used to stratify outcomes. There were no significant differences between 
preoperative characteristics or operation types among patients with nosocomial infections 
versus those without. In performing the analysis, a serum glucose value of less than or 
equal to 220 mg/dL was considered to represent good glucose control. Patients were 
monitored for infection rates up to discharge or a maximum of 14 PODs for a prolonged 
hospitalization. 
A single blood glucose value greater than 220 mg/dL on POD 1 was associated 
with an infection rate of 31.3%. The infection rate was 11.5% (p<0.05) when all of a 
patient"s blood glucose levels were less than 220 mg/dL (Table 2) (16). The most 
common complications were leg wound infection (10.9%), urinary tract infections 
(6.6%), sternal wound infections (5.6%), and pneumonia (4.6%) (2). 
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Pomposelli eta! also examined the affect of hyperglycemia on infection 
incidence. Patients who developed nosocomial infections on POD 1 were more likely to 
have a higher perioperative maximum and mean glucose levels than those who did not 
develop an infection. Moreover, when simple infections of the UTis were excluded, 
hyperglycemia greater than 220 mg/dL was associated with a 5.8 fold increase in the 
nosocomial infection risk in comparison to patients with levels less than 220 mg/dl 
(24.6% vs. 4.2%, p < 0.03) (16). However, since the researchers did not mention the 
desire to analyze the data without including UTis a priori, I was concerned that they were 
modifying the data in an attempt to obtain the result they desired. 
QUALITY OF THE STUDIES 
Quality of the Golden study 
In the Golden study, all diabetic patients who had coronary bypass surgery at an 
urban hospital participated. The researchers adjusted for differences in the patient 
characteristics by using the Charlson Comorbidity Index and the APACHE III score. The 
patients in each group were equally likely to have had an infection identified by the 
inpatient health care team. 
In determining the presence of infection, the health care team used the same 
methods to follow patients in both groups. There was complete follow up of all patients 
in the time period allocated for the study by the researchers. The study accurately 
assessed risk factor for postoperative infection ascertainment, risk factor for 
postoperative infection reporting, defining of outcomes, outcome ascertainment, outcome 
reporting and adjustment of the outcome data (Table 3). 
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This study was a cohort study which only allowed for an association between 
hyperglycemia and postoperative infection to be determined from the results. However, 
the results of the adjusted data were not statistically significant. Additionally, although 
temporality was shown with hyperglycemia appearing prior to the onset of an infection, 
other Bradford-Hill criteria were absent. The study did not show sufficient strength of 
association with RORs from 1.17-1.86. There also was no dose-response curve in the 
primary analysis with ROR values going from 1.17 up to 1.86 and then down to 1.72 by 1 
quartile. 
However, a non- statistically significant dose response curve was present in the 
secondary analysis which controlled for infectious complications on POD 2. The lack of 
a statistically significant association between hyperglycemia and infection rates does not 
in itself support a valid association. However, even if an association was suggested by 
the data, I would have been unable to assign a causal relationship to hyperglycemia and 
postoperative infection since many of the Bradford-Hill criteria were absent. 
Another limitation was that there was little information related to pre-existing 
diabetic microvascular disease, such as retinopathy, nephropathy and neuropathy. The 
authors indicated that it was impossible to determine whether poor perioperative control 
was simply indicative of poor long-term control and pre-existing microvascular disease. 
Second, it was possible that subclinical infection within 36 hours following surgery 
actually led to hyperglycemia. 
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Finally, this was an observational study in which the level of glycemic control 
was not assigned and physicians might have chosen tighter control for patients with 
perceived higher risk of infection or a higher risk of hyperglycemia (2). Additionally, 
there could have been patients with good control prior to entering the study. These 
patients are less likely to become infected and to have better postoperative outcomes. 
The authors observed that the relationship of peri operative glycemic control to 
complication risk was independent of age and proteinuria and that comorbidity reduces 
t 
the likelihood that this limitation influenced the results (2). The results of the lagged L 
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analysis suggested that the hyperglycemia was not the result of pre-existing subclinical 
infections (2). If physicians were more likely to choose tighter control in patients 
perceived to be at higher risk, the results could have been biased toward the null causing 
the true risk associated with hyperglycemia to be underestimated (2). Additionally, if the 
patients were already well controlled and perceived to be at lower risk, the physicians 
could have been more likely to choose less rigorous control in these patients. This could 
cause the risk to be overestimated in these patients. 
Quality of the Pomposelli study 
Pomposelli et al used groups with a similar risk of peri operative infection. 
Uninfected diabetic patients undergoing elective surgery were enrolled. Patients with 
evidence of a preoperative infection, who were imrnunocompromised, or who required 
hemodialysis were excluded to eliminate other characteristics that could have potentially 
increased a patient's infectious risk. The APACHE II score, a score predicting mortality 
in critically ill patients, was used to adjust for potential confounders during analysis. 
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The clinical team used this score to identify patients' nosocomial infection status. 
The researchers had complete information on all included patients from POD 2 to POD 
14. This study accurately defined the diabetic population, determined risk factor for 
postoperative infection ascertainment, defined outcome ascertainment, reported outcome 
and adjusted outcome data for potential confounders (Table 3). 
This also was a cohort study and so only a non-causal association can be 
determined from the results. Pomposelli et a! showed a lower infection incidence of 
11.5% when all of patient's blood glucose levels were less than 220 mg/dL. This result 
was statistically significant. However, the most impressive difference, a 5.8 fold increase 
in nosocomial infection risk, was seen in patients with blood glucose levels greater than 
220mg/dL in comparison to those with levels less than 220mg/dL. However, this data 
was tabulated after UTI data was removed. This analysis is questionable since the 
researchers did not decide a priori to perform it. 
The temporality of the presence of hyperglycemia prior to nosocomial infection 
was established. Some association between hyperglycemia and nosocomial infections 
was shown with patients with levels less than 220mg/dL. These patients were found to 
have a statistically significant lower infection risk (11.5%) in comparison to those with 
levels greater than 220 mg/dL (31.3%). However, the strength of this association was not 
clear because of the methods used by the researchers in obtaining some of their results. 
Moreover, there was no dose-response curve shown in this study nor was reversibility 
addressed. 
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Neither of these studies attempted to implement an "optimal control protocol". 
These studies are simple observations and as such much more likely not to lead to the 
determination of a causal link. Patients with good control will have better perioperative 
control and will be inherently less likely to have complications. It says almost nothing 
about their hospital care. 
Studies Not Meeting Inclusion Criteria 
Two studies that did not meet review criteria, but can help in understanding 
research in this field, were by Latham eta! (17) and Furnary eta! (18). Latham assessed 
the importance of diabetes, diabetes control, hyperglycemia, and previously undiagnosed 
diabetes in the development of surgical site infections among cardiothoracic surgery 
patients. Patients having coronary artery bypass or cardiac valvular procedures at Saint 
Thomas Heart Institute in Tennessee were followed prospectively to identify those who 
developed surgical site infections (SSis) (17). 
One thousand patients in the Latham study had HgA1c determinations performed 
preoperatively to determine their diabetic status. The normal values were determined to 
be between 4.2% and 6.2%. Thirty patients out of the initial one thousand were found to 
have surgical site infections (SSis). Forty-four additional cardiothoracic surgery patients, 
not enrolled in the HgAlc evaluation, were also identified through routine surveillance as 
having developed SSis. The seventy-four infected patients (thirty initial patients plus the 
forty-four added patients) were the cases and the nine hundred and seventy initially 
uninfected patients served as the controls when the researchers looked at the effects of 
hyperglycemia on SSI rates. 
22 
L 
-
' l 
L 
According to the Latham study, twenty-six (62%) of the forty-two patients with 
known diabetes with SSis had hyperglycemia after surgery compared with one hundred 
and twenty three (44%) of two hundred and seventy eight diabetics without SSis who did 
not (odds ratio [OR], 1.86; 95% confidence interval (CI 95), [1.04- 3.34]; P=0.03) (17). 
The ORs ofSSI s were 2.54, 2.97 and 3.32 among patients with postoperative glucose 
levels of200 to 249,250 to 299, and 300mg/dL or greater, respectively (compared to 
those with levels less than 200 mg/dL; P<0.0001) (17). Confidence intervals for Ors 
were not given in the paper (17). 
Fumary eta! conducted a study of tight glucose control using continuous 
intravenous insulin infusion (CII) compared to sliding scale guided intermittent 
subcutaneous insulin injections (SQI). Incidence of deep sternal wound infections 
(DSWI) in diabetic patients after cardiac surgical procedures was the primary outcome. 
The Portland CII protocol consisted of a starting intravenous insulin infusion dosage, 
frequent blood glucose testing, insulin infusion titration, and stopping orders. 
In the Fumary study, all known diabetic patients consecutively admitted to 
Portland St. Vincent Medical Center for open heart surgical procedures between January 
1987 and November 1997 were entered (n=2467) (18). Nine hundred and sixty-eight 
diabetic patients were operated on between January 1, 1987 and September 1, 1991 and 
placed in a group which received individualized sliding scale guided SQis as the method 
of postoperative glucose regulation. 
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The remaining 1499 diabetic patients operated on between September 1991 and 
November 1997, were cared for using the en protocol (Appendix 1) for glucose 
regulation. The SQI group was treated every four hours to keep blood sugar at or below 
200mg/dL (18). The en group had the insulin drip titrated on the basis of the most 
recent fingerstick glucose measurement to maintain blood glucose levels between 150 
and 200 mg/dL (18). 
Overall, 31 of the 2467 diabetic patients developed deep sternal wound infections 
(1.3%) (18). Daily comparison of mean blood glucose levels between the SQI and en 
groups demonstrated tighter control in the err group. Mean blood glucose levels on the 
day of operation through the third POD were significantly lower within the en group 
than in the SQI group (199 ± 1.4 versus 241 ± 1.9 mg/dL on the day of operation, 176 ± 
0.8 versus 206 ± 1.2 mg/dL on POD 1, 181 ± 1.2 versus 195 ± 1.3 mg/dL on POD 2, and 
179 ± 1.5 versus 188 ± 1.4 mg/dL on POD 3, en group versus SQI group, respectively; 
p<O.OOOl for all comparisons) (18). 
The implementation of the en protocol resulted in a 2.5-fold decrease in the rate 
ofDSWI compared with that for SQI (18). The rate ofDSWI dropped from 1.9% (19 of 
968) with SQI to 0.8% (12 of 1,499) with err (p = 0.011) (18). The absolute difference 
between these two protocols was 1.1% (1.9-0.8). This means that approximately 100 
patients need to be treated with the protocol to prevent one DSWI. 
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Quality of the Studies 
Quality of the Latham study 
The association between hyperglycemia and SSis appeared to be significant with 
a dose-response curve present. However, this was a poorly done case-control study. The 
weakness in the study stems from the method the researchers used in selecting patients. 
The researchers admitted forty-four patients, not originally sent for HgAl c evaluation, 
after finding out they had SSis. The authors appeared to be trying to increase the number 
of cases to make their data significant. 
Quality of the Fumary Study 
The SQI and CII groups were diabetics having the same type of surgical 
procedures performed by the same surgical team. The researchers adjusted for the 
baseline differences between groups when analyzing the outcome data. First, the 
researchers performed a descriptive analysis of all demographic and patient characteristic 
data. They then performed a multivariate analysis of all individual variables with a 
possible association with DSWI. They felt that both groups were equally as likely to 
have had their outcomes identified by the clinical team because all patients were closely 
monitored in the hospital. 
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A limitation of the Furnary study was that the patients were classified into 
sequential groups. One protocol used patients from 1987 - 1991, and another protocol 
used in patients from 1991 -1997. Therefore, this was a historical cohort study 
conducted over consecutive admission periods. This approach could cause selection bias 
since the patients from the later years could have been healthier, come from a different 
referral base, or been treated more effectively secondary to temporal advances in 
l--
medicine and surgery during that time. 
Neither Latham nor Furnary addressed other prior health conditions besides the 
presence of diabetes in a patient's likelihood of developing infection. If the patient 
already had depressed immune system function secondary to previously uncontrolled 
health problems, he or she could be at higher risk of becoming infected. This would bias 
the researchers' estimates of infection rates because these patients were more likely to 
suffer from an infection. Therefore, the authors should have analyzed the data after 
taking other possible confounders (e.g. coexisting chronic diseases and likelihood of poor 
outcomes) into account 
SUMMARY OF RESULTS 
The main question from the results of the studies presented is whether or not there 
is an association between hyperglycemia and postoperative infections. Golden et a! 
found a non -statistically significant association between hyperglycemia and 
postoperative infectious complications. Pomposelli eta! found a statistically significant 
and large difference with fewer patients (N=1 00). However, the analytic strategy is 
questionable. The evidence for an association between reduced blood glucose levels and 
fewer postoperative infections from the included studies was weak. 
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Latham et al was a poorly done case control study where the researchers added 
cases at the end of a cohort study. In this study, the researchers showed that glycemic 
control made a difference in infection rates in wound and other study sites. The method 
used by the researchers when they conducted this study makes the evidence acquired 
from it poor. Fumary et a! found a small difference (NNT = 1 00) with a historical cohort. 
A historical cohort study is one where patients are identified from past records 
and followed forward from that time up to the present (13). This study design often 
produces data that may not be of sufficient quality for rigorous research (13). Therefore, 
this study design and the lack of an appropriate control group made the evidence for an 
association between hyperglycemia and DSWis fair. 
Another limitation of these studies was that blinding was not a part of the research 
process. This process could have taken place at four levels in the clinical trial. First, 
those responsible for allocating patients to treatment groups should not know which 
treatment will be assigned next so that the knowledge does not affect their willingness to 
enter patients in the trial or take them in the order they arrived (13). Second, patients 
should be unaware of whether they are in the treatment group or the control group; they 
are thereby less likely to change their compliance or their reporting of symptoms because 
of this information (13). 
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Third, the physicians who take care of patients in the study should not know 
which treatment each patient has been given; such that they will not, perhaps even 
unconsciously, manage them differently (13). Finally, it the researchers who assess 
outcomes cannot be allowed to distinguish treatment groups; that knowledge carmot 
affect their measurements (13). If blinding were incorporated into a study, the internal 
validity of the study can be maintained and the conclusion that could be inferred from the 
data would be stronger. 
DISCUSSION 
There have been no RCTs that addressed reducing postoperative infections in 
diabetic surgical patients. In the two included cohort studies, the case control study and 
the historical cohort study showed weak evidence that postoperative infections can be 
reduced with tighter perioperative glycemic control. My personal assessment of the 
results was that overall evidence was weak, but leaning in a positive direction. If better 
perioperative control might lead to fewer postoperative infections they why should we 
not strive for it? Are there potential consequences for obtaining better control? The 
implementation of "weak" evidence is controversial. 
The included studies did not address adverse events that could result from this 
type of action. For example, would implementing this evidence waste resources on 
ineffective treatment? A significant amount of time and money would have to be used to 
implement a protocol for better glucose control. Nurses and other health care workers 
would have to increase monitoring of diabetic patients on the wards. This means the 
patients would have to endure more blood glucose checks and insulin injections. 
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Additionally, due to the increase in the administration of insulin, there is greater 
possibility of hypoglycemic episodes thus, increasing morbidity and/or mortality on 
diabetic patients. With the current evidence that exists at the present, it might be too 
much work for the little benefit that can be gained from implementing this protocol. 
I wish there were RCTs available so that a cause and effect relationship could 
have been developed and reversibility could have been established between 
hyperglycemia and postoperative infections. The lack of a RCT in this area was a major 
problem in addressing this issue. Cohort studies do not allow for general 
recommendations for the management of diabetic patients undergoing surgical 
procedures to be given. 
However, some recommendations can be given for taking care of individual 
diabetic patients. The results suggested that blood glucose levels of approximately 250 
mg/dL or lower appeared to be associated with decreased infection incidence in diabetic 
patients. Therefore, if a physician is seeing a patient who is planning to undergo a 
surgical procedure, one might want to attempt to lower his or her blood glucose to 250 
mg/dL or lower. 
Unfortunately, beyond recommendations for the care of an individual patient, no 
guidelines can be made for the general population until causation is established between 
hyperglycemia and postoperative infections. 
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Associ.ation is not causation and association is all that can be drawn from cohort 
studies. Had the studies met the Bradford-Hill criteria, then I could say that the 
association between hyperglycemia and postoperative infection was causal. Although all 
the studies showed temporality and some showed a dose-response curve, many of the 
Bradford-Hill criteria were not met. Reversibility could not be shown in any of the 
studies due to their designs. 
Consistency was not observed since the different studies obtained different results 
in their diabetic patients. In the Golden eta! study, even if the results had been 
statistically significant, the researchers only found a small difference in infection between 
the quartiles (2). In contrast, Pomposelli eta! found a statistically significant and large 
difference. Biologic plausibility has not conclusively been established on whether or not 
diabetics have an increased risk of infection in comparison to patients without diabetes 
(19). There is also no conclusive evidence that hyperglycemia causes diabetics to have 
an increased risk of postoperative infection. 
Limitations of the Review 
No randomized controlled trials were identified in the systematic literature search. 
There were only two prospective cohort studies found during this search. The lack of 
studies may be due to negative articles not being published (14). 
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Finding a limited amount of evidence related to my study question made it 
difficult to fully determine the role of tight glucose control on perioperative outcomes in 
diabetic patients. Without randomized controlled trials, the apparent relationship 
between the perioperative infections outcomes and glycemic control could not be fully 
determined. Another limitation is that only one reviewer evaluated the studies for 
inclusion, data abstraction and quality assessment. Ideally, several reviewers should be 
involved with formal testing of inter-rater reliability (14). 
CONCLUSION 
Practice Implications 
Clinically, I am not sure that there is an association between hyperglycemia and 
postoperative infection incidence in diabetic surgical patients. There is a weak suggested 
association according to the evidence provided here, but it is far from clear. Some groups 
have already made recommendations (3, 4, and 5); however, there is little evidence to 
back them. 
The evidence available at present makes it impossible to issue practice guidelines 
for the medical community to follow. However, I feel the evidence may be strong 
enough to make recommendations on an individual patient level. If a physician is seeing 
a patient, he or she might attempt to lower the patient's blood glucose as much as 
possible since the benefits would likely outweigh the potential risks to the patient. 
Suggestions for Further Research 
It would be helpful to have more research into the possible relationship between 
hyperglycemia and postoperative infection. The ideal research would be to have a 
randomized control trial so that a cause and effect relationship could be established. 
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However, conducting such a study would have many ethical implications. Placing 
patients into categories of "good" versus "bad" control would be difficult. However, a 
study looking at tight control versus standard care would be perfectly ethical. This is 
particularly true given the uncertainty about whether tight perioperative control improves 
outcomes or simply results in increased costs and morbidity (16). 
Outside of the needed RCT there are several studies which could be done with 
existing data. One suggestion could be to look at the data from the UKPDS study and 
collect chart data from the participants who had surgeries. Then, for those patients, find 
out how many had tight or loose control of their blood glucose levels at that time of their 
operation and look at the infection rate between the two groups. The advantage to this 
type of study is that the preoperative records are more likely to be good and it would be 
relatively easy to obtain this data from the patients who participated in the study. 
However, there could be too few patients who had surgery during the time frame of the 
study or surgical outcomes may not have been collected uniformly. 
L 
Another idea would be to look at cross-sections hospitals that are aggressive in ¥-
controlling glucose levels in their surgical patients versus those that are not as aggressive 
and compare infection rates between the institutions. This type of study could assist in 
addressing whether or not aggressive control makes a difference in postoperative 
infection rates. Additionally, it would allow possible adverse outcomes from better 
glycemic control to be addressed through hypoglycemic episode recording and nursing 
log data. However, it would be difficult to compare different hospitals in different 
locations, different patient populations and different perioperative glycemic control 
protocols. 
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Moreover, a time series study could be conducted in other countries. In a time 
series study, the effect is measured at various points in time before and after the 
purported cause has been introduced (13). If changes in the purported cause are followed 
by changes in the purported effect, the association is less likely to be spurious (13). 
An example of this would be to go to another area (e.g. India or Africa) that has no 
protocol in place for managing diabetic surgical patients. Then, begin a tight 
perioperative control protocol that is used in the U.S. The infection rates five years after 
beginning this protocol could be compared to infection rates from five years prior to the 
protocol's inception to see what, if any, difference tight perioperative control made in the 
infection rate in these countries. 
This type of study would allow the effect of a particular protocol on infection rate 
to be established. There would be no issue of varying perioperative glycemic control 
protocols, because all hospitals would use the protocol given to them by the researchers. 
However, there would be some temporal bias since a comparison would be made between 
data from two different time points. 
These suggestions could be implemented with both financial and organizational 
planning. However, due to the many flaws that are associated with these types of study 
designs, the only conclusive method of determining a causal relationship between 
hyperglycemia and postoperative infection would be to conduct a RCT. Therefore, future 
research should be directed into having a RCT conducted in this area. Only this type of 
study will afford the answer to the question posed in this paper. Since, the number of 
patients that will suffer from this disease in the future is continuing to rise, it is 
imperative that this type of research be conducted. 
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Table 1: 
Two Studies with Diabetic Patients with Other Infectious Outcomes 
Study design Outcomes Perioperative Perioperati ORorRR 
Citation and patient outcome ve outcome (95% CI) 
population present absent 
jtotalN) 
Golden et Cohort Study: Leg and Quartile 1: Quartile 1: Quartile 1: 
a! Patients were chest 21/104 83/104 OR 1:00 
1999 (2) followed to wounds, 
compare pneumoma, Quartile 2: Quartile 2: Quartile 2: 
infection and UTis 22/102 80/102 OR: 0.94 
incidence in (0.39-2.26) 
patient with Quartile 3: Quartile 3: 
lower glucose 31/104 73/104 Quartile 3: 
levels (Quartile OR: 1.59 
I)* to those with Quartile 4: Quartile 4: (0.71-3.54) 
higher levels 26/101 75/101 
(Quartiles 2-4)* Quartile 4: 
(N=411) 1.78(0.79-
4.05) 
Pomposell Prospective Nosocomial ::::220 mg/dl: ::::Z20mg/dl : NA 
i eta! cohort study: infection 1/24 23/24 
1998 (13) Diabetic patients (4.2%) (95.8%) 
undergoing 
elective surgery >220mg/dl: >220mg/dl: NA 
were monitored 15/61 46/61 
for perioperative (24.6%) (75.4%) 
glucose control 
and nosocomial 
infection 
(N=97) 
Quartile 1: blood glucose levels: 121-206 mg/dL. Quartile 2: 207-229 mg/c!L. Quartile 3: 
230-252 mg/dL. Quartile 4: 253-352 mg/dL. 
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p 
value 
0.03 
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Table 2: 
Blood Glucose and Infection Rate Contingency Tables for Each Study 
Day (Pomposelli et al1998) (16) 
Highest glucose Be'came Remained Total Infection 
(mg/dl) infected uninfected rate(%) 
A: <220 15 47 62 24.2 
Preop >220 9 26 35 25.7 
Total 24 73 97 24.7 
B: <220 3 23 26 11.5 
POD I >220 21 46 67 31.3 
Total 24 69 93 25.8 
C: <220 9 30 39 23.0 
POD2 >220 14 37 51 27.5 
Total 23 67 90 25.6 
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p 
value 
0.87 
0.05 
0.63 
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Table 3: 
Quality of Included Studies 
Study l.DM 2.DM 3.RF 4.RF s.oc 6. oc 7. oc s.oc 9.0C 
number Definition Surveillance Ascertain- Reporting Definition Ascertain- Blinding Reporting Adjust-
ment ment ment 
I. 
- -
+ + + + 
-
+ + 
Golden 
(7) 
2. + 
-
+ + + + 
-
+ + 
Pomposel 
li (13) 
1. DM definition- a specified glycemic threshold, use of glucose-lowering agents, or both were used to define diabetes; 
2. DM Surveillance - a protocol to detect DM was described the proportion of patients not identified in initial screening of patients for study; 
3. Risk factor for postoperative infection ascertainment - methods to determine risk factors were described and similarly applied to study subjects and 
control subjects; 
4. Risk factor for postoperative infection reporting- all factors evaluated (not just those that were significant) were reported; 
5. Outcomes definition- diagnostic criteria for all outcomes assessed were described; 
6. Outcomes ascertainment - methods to determine the outcomes were described and similarly applied to patients with and without infection; 
7. Outcomes blinding- outcomes were assessed by investigators blind to diabetes status; 
8. Outcomes reporting- outcomes obtained by the investigators were described; 
9. Outcomes adjustment - prognostic estimates were adjusted for differences between those with and without infection; 
+, study met my review's methodological study criterion; -, study did not meet my review's methodological quality criterion. (Model for this table was 
adapted from Montori VM et al. Posttransplantation Diabetes: A Systematic Review of the Literature. Diabetes Care. Volume 25, number 3, March 2002.) 
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APPENDIX 
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Appendix 1: 
Portland Protocol for Continuous Intravenous Insulin Infusion in 
Postoperative Diabetic Patients Undergoing Cardiac Surgical 
Procedures (Furnary et al1999) (21) 
I. Start insulin infusion through pump piggyback to maintenance intravenous infusion as follows: 
Test blood glucose level by fingerstick method or arterial line drop sample: 
Blood Glucose (mg/dL) Insulin (units/h) 
<ISO 0 
!50- 200 I 
201-250 2 
>251 3 
2. Frequency of blood glucose testing: 
a. Every hour until stable (when frequent changes in insulin dosage are no longer 
necessary, and glucose is in the range !50 to 200 mg/dL); then test every 2 hours. 
b. When weaning from vasopressors (e.g., epinephrine), check every 30 minutes 
until stable. 
c. May stop testing every 2 hours on postoperative day 3 [see item 4]. 
3. Insulin titration: 
Blood Glucose 
<75 
75-100 
Stop insulin; give 25 mL of 50% dextrose 
injection and recheck blood glucose in 
30 min; when blood glucose is> !50 
mg/dL, restart with rate 50% of 
previous rate 
Stop insulin; recheck blood glucose in 30 min, 
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101-150 
151-200 
201-250 
>250 
when blood glucose is >150 mg/dL, restart with rate 
50% of previous rate 
If <10% lower than last test, decrease 
rate by 0.5 unitslh; if> 10% lower than 
last test, decrease rate by 50% 
Same rate 
!flower than last test, use same rate; if higher than last 
test, increase the rate by 0.5 units/h 
If> 10% lower than the last test, use same rate; if <1 0% 
lower than last test, increase rate by 1 unitlh 
If blood glucose is >251 mg/dL and has not decreased after three hourly increases in insulin, then 
double insulin rate. 
4. Start continuous intravenous insulin protocol during operation and continue postoperatively 
through the day of operation and continue postoperatively through the day of operation and the 
first and second postoperative days. Patients who are not receiving enteral nutrition on the third 
postoperative day should remain on this protocol until receiving at least a soft American Diabetes 
Association diet. 
5. American Diabetes Association diabetic diet starts with any oral intake. 
6. On the third postoperative day, restart preadmission glycemic control medications when patient 
is tolerating soft diet. If not tolerating soft diet, consult physician for new orders at that time. 
7. For patients with previously undiagnosed diabetes mellitus and hyperglycemia: start Portland 
protocol ifblood glucose is> 200 mg/dL. Consult endocrinologist on postoperative 2 for 
diabetes mellitus workup and follow-up orders. 
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